Safety and Efficacy Trial of Beclomethasone Dipropionate in Allergic Rhinitis
- Study Title
- Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 Mcg in Female, Maleergic Rhinitis
- Teva Identifier
- BDP-AR-303
- ClinicalTrials.gov Identifier
- NCT00988247
- Study Status
- Completed
- Trial Condition(s)
- Rhinitis, Female, Maleergic, Perennial
- Interventions
- Drug: Beclomethasone dipropionate | Drug: Placebo Nasal Aerosol
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 12 Years and older
- Trial Duration
- 10/01/2009 - 02/01/2011
- Phase
- Phase 3
